These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18421061)

  • 1. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials.
    Nguyen PL; D'Amico AV
    J Clin Oncol; 2008 Apr; 26(12):2055-6; author reply 2056-7. PubMed ID: 18421061
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer, and confusion about the results of the randomized trials.
    Roach M
    J Clin Oncol; 2008 Aug; 26(22):3816-7; author reply 3817-8. PubMed ID: 18669477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is pelvic irradiation still justified in the treatment of prostate cancer by exclusive radiotherapy?].
    Chapet O; Quero L; Azria D; Bossi A; Hennequin C; Paparel P
    Cancer Radiother; 2009 Sep; 13(5):416-22. PubMed ID: 19167919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of extended-field radiotherapy for prostatic neoplasm: 1976 progress report.
    Bagshaw MA; Pistenma DA; Ray GR; Freiha FS; Kempson RL
    Cancer Treat Rep; 1977; 61(2):297-306. PubMed ID: 872133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To treat pelvic nodes or not: could the greater testicular scatter dose from whole pelvic fields confound results of prostate cancer trials?
    King CR; Kapp DS
    J Clin Oncol; 2009 Dec; 27(36):6076-8. PubMed ID: 19858377
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphatic drainage and CTV in carcinoma of the prostate.
    Cellini N; Luzi S; Mantini G; Mattiucci GC; Morganti AG; Digesù C; Bavasso A; Deodato F; Smaniotto D; Valentini V
    Rays; 2003; 28(3):337-41. PubMed ID: 15018322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy for node-positive prostate cancer: it's time for a randomized trial.
    Nguyen PL
    Oncology (Williston Park); 2015 Feb; 29(2):116-7. PubMed ID: 25683832
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility of IMRT to cover pelvic nodes while escalating the dose to the prostate gland: dosimetric data on 35 consecutive patients.
    Bayouth JE; Pena J; Culp L; Brack C; Sanguineti G
    Med Dosim; 2008; 33(3):180-90. PubMed ID: 18674682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node assessment and lymphadenectomy in prostate cancer.
    Ordon M; Nam RK
    J Surg Oncol; 2009 Mar; 99(4):215-24. PubMed ID: 19170044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is elective pelvic lymph node irradiation indicated in definitive radiotherapy for localized prostate cancer?
    Mendenhall WM; Hoppe BS; Nichols RC; Henderson RH; Mendenhall NP
    Am J Clin Oncol; 2013 Dec; 36(6):644-7. PubMed ID: 22237149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pelvic irradiation in prostate cancer: what place for what volumes?].
    Chapet O; Enachescu C; Lorchel F
    Cancer Radiother; 2013 Oct; 17(5-6):562-5. PubMed ID: 23993883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?
    Da Pozzo L
    Eur Urol; 2008 Sep; 54(3):541-2. PubMed ID: 18602740
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of elective pelvic radiotherapy in clinically node-negative prostate cancer: a systematic review.
    Dirix P; Joniau S; Van den Bergh L; Isebaert S; Oyen R; Deroose CM; Lerut E; Haustermans K
    Radiother Oncol; 2014 Jan; 110(1):45-54. PubMed ID: 23993400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.
    Bastide C; Brenot-Rossi I; Garcia S; Rossi D
    Eur J Surg Oncol; 2009 Jul; 35(7):751-6. PubMed ID: 18538526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation in high-risk prostate cancer: how much is enough?
    Payne H
    BJU Int; 2008 Sep; 102(6):663-5. PubMed ID: 18476968
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era: change you can believe in, or back to the future? (In regard to Nguyen PL, et al. (Int J Radiat Oncol Biol Phys 2009).
    Roach M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):316; author reply 316. PubMed ID: 19695446
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer: pelvic nodes revisited--sites, incidence and prospects for treatment with radiotherapy.
    Neal AJ; Dearnaley DP
    Clin Oncol (R Coll Radiol); 1993; 5(5):309-12. PubMed ID: 8305340
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of micrometastases in prostate cancer.
    Fujisawa M; Miyake H
    Surg Oncol; 2008 Sep; 17(3):247-52. PubMed ID: 18556193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.